Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-30
1999-10-05
Dentz, Bernard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514266, 514300, 546113, 546118, 546121, 544277, A61K 31435, C07D47104
Patent
active
059624701
ABSTRACT:
Compounds of formula (I): ##STR1## azaindolyl, azaindolinyl, imidazopyridyl or imidazopyrimidinyl group; Y represents an oxygen or sulfur atom; Z represents a 2,4-dioxo-thiazolidin-5-ylidenylmethyl, 2,4-dioxothiazolidin-5-ylmethyl, 2,4-dioxooxazolidin-5-ylmethyl, 3,5-dioxo-oxadiazolidin-2-ylmethyl or N-hydroxyureidomethyl group; R represents a hydrogen atom, an alkyl group, an alkoxy group, a halogen atom, a hydroxy group, a nitro group, an aralkyl group or a unsubstituted or substituted amino group; and m is an integer of from 1 to 5! have hypoglycemic and anti-diabetic activities.
REFERENCES:
patent: 4572912 (1986-02-01), Yoshioka et al.
patent: 4691027 (1987-09-01), Yoshioka et al.
patent: 4871762 (1989-10-01), Yoshioka et al.
patent: 4873225 (1989-10-01), Yoshioka et al.
patent: 5104888 (1992-04-01), Yoshioka et al.
patent: 5143930 (1992-09-01), Yoshioka et al.
patent: 5338855 (1994-08-01), Yoshioka et al.
patent: 5387596 (1995-02-01), Takebayashi et al.
The Ring Index--2nd Edition, Austin Patterson et al (America Chemical Society), p. 157 (1960).
Fujimoto Koichi
Fujita Takashi
Fujiwara Toshihiko
Horikoshi Hiroyoshi
Oguchi Minoru
Dentz Bernard
Sankyo Company Limited
LandOfFree
Heterocyclic compounds having anti-diabetic activity and their u does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds having anti-diabetic activity and their u, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds having anti-diabetic activity and their u will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1171787